Large-scale plasma proteomic profiling unveils diagnostic biomarkers and pathways for Alzheimer’s disease
Top Cited Papers
- 20 May 2025
- journal article
- Published by Springer Nature in Nature Aging
- Vol. 5 (6) , 1114-1131
Abstract
Proteomic studies have been instrumental in identifying brain, cerebrospinal fluid and plasma proteins associated with Alzheimer's disease (AD). Here, we comprehensively examined 6,905 aptamers corresponding to 6,106 unique proteins in plasma in more than 3,300 well-characterized individuals to identify new proteins, pathways and predictive models for AD. We identified 416 proteins (294 new) associated with clinical AD status and validated the findings in two external datasets representing more than 7,000 samples. AD-related proteins reflected blood-brain barrier disruption and other processes implicated in AD, such as lipid dysregulation or immune responses. A machine learning model was used to identify a set of seven proteins that were highly predictive of both clinical AD (area under the curve (AUC) of >0.72) and biomarker-defined AD status (AUC of >0.88), which were replicated in multiple external cohorts and orthogonal platforms. These findings underscore the potential of using plasma proteins as biomarkers for the early detection and monitoring of AD and for guiding treatment decisions.Keywords
All Related Versions
Funding Information
- U.S. Department of Health & Human Services | NIH | National Institute on Aging (R01AG044546)
This publication has 66 references indexed in Scilit:
- Mild cognitive impairment: a concept in evolutionJournal of Internal Medicine, 2014
- Cut-off Scores of a Brief Neuropsychological Battery (NBACE) for Spanish Individual Adults Older than 44 Years OldPLOS ONE, 2013
- Normative data of a brief neuropsychological battery for Spanish individuals older than 49Journal of Clinical and Experimental Neuropsychology, 2012
- Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization InitiativeAlzheimer's & Dementia, 2011
- The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseAlzheimer's & Dementia, 2011
- The Uniform Data Set (UDS): Clinical and Cognitive Variables and Descriptive Data From Alzheimer Disease CentersAlzheimer Disease & Associated Disorders, 2006
- Risk Factors for Mild Cognitive Impairment in the Cardiovascular Health Study Cognition StudyArchives of Neurology, 2003
- Mild Cognitive ImpairmentArchives of Neurology, 1999
- Decreased phospholipase A2 activity in Alzheimer brainsBiological Psychiatry, 1995
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984